Berkenblit Anna 4
4 · ImmunoGen, Inc. · Filed Feb 25, 2020
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Sale
Common Stock
2020-02-24$4.99/sh−25,803$128,757→ 98,089 total
Footnotes (2)
- [F1]Weighted average price of shares sold.
- [F2]The transaction reported in this Form 4 was made in connection with the satisfaction of the reporting person's tax withholding obligation arising from the vesting of restricted shares and was effected pursuant to a 10b5-1 trading plan executed by the reporting person.